State AGs Expand Investigation of Opioid Manufacturers, Distributors; Ask Insurers to Review Payment, Coverage Terms

By: Jeffrey Lynne September 25, 2017 1:50 am

Time to read: 5 Minutes

State AGs Expand Investigation of Opioid Manufacturers, Distributors; Ask Insurers to Review Payment, Coverage Terms

​A bipartisan group of 41 state attorneys general (AGs) are expanding their investigation of the role pharmaceutical manufacturers and distributors have played in the nation’s opioid epidemic.

The AGs announced September 18 that subpoenas and document requests were sent to five pharmaceutical manufacturers and three distributors as part of a multistate investigation into the companies’ marketing, distribution, and sale of opioids.

The subpoenas were sent to manufacturers Endo International plc, Janssen Pharmaceuticals, Teva Pharmaceutical Industries Ltd./Cephalon Inc.; and Allergan Inc. and distributors Amerisource Bergen, Cardinal Health, and McKesson, which account for 90% of the nation’s opioid distribution. Colorado AG Cynthia Coffman indicated that a supplemental subpoena also was issued to Purdue Pharma.

New York Attorney General Eric T. Schneiderman said the subpoenas “mark a major expansion of the investigations by the Attorneys General into the nationwide opioid epidemic.”

A day earlier, 37 state AGs signed a letter urging insurers to review their payment and coverage polices with an eye toward ensuring they incentivize health care providers to prioritize non-opioid pain management whenever possible.

“The opioid epidemic is the preeminent public health crisis of our time,” said the September 18 letter to America’s Health Insurance Plans President and Chief Executive Officer Marilyn Tavenner.

“The unnecessary over-p
rescription of opioid painkillers is a significant factor contributing to the problem,” the letter noted. “Insurance companies can play an important role in reducing opioid prescriptions and making it easier for patients to access other forms of pain management treatment,” the AGs urged.

Note: Appreciation is extended to the American Health Lawyers Association (AHLA) for preparing this news release.

Jeffrey Lynne

Jeffrey Lynne is a partner at Beighley, Myrick, Udell, Lynne + Zeichman, P.A. in both the firm’s Land Use & Zoning and Governmental Affairs & Regulated Industries practice groups. He also chairs the Firm’s Behavioral Healthcare Practice Group and represents clients with local, state and federal zoning, permitting, licensing, and regulatory matters. Mr. Lynne received his undergraduate education at the University of Florida and attended law school at the University of Miami (1997).

Copyright © 2024 Beighley, Myrick, Udell Lynne + Zeichman.